MODI’IN, ISRAEL, ISRAEL, December 8, 2021 /EINPresswire.com Total financing for market launch and penetration surpasses $9 million mark Breakthrough “FIZE kUO™” device for monitoring real-time kidney urine output to enter…
Vancouver, B.C. and Boston, MA, November 8, 2021 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) “Imagin” or the “Company”), a surgical imaging company visualizing cancer in vital new ways…
Rapha Capital BioVentures Fund I, LP (RCBVFI) managed by Rapha Capital leads the financing. Kevin Slawin, M.D., a leading urooncologist and manager of RCBVFI, joins the board. Imagin Medical’s i/Blue™…
Rapha Capital BioVentures Fund I, LP (RCBVFI), Leads New Convertible Note Financing Kevin Slawin, MD, a Leading UroOncologist and Manager of RCBVFI Joins the Board Imagin Medical’s i/Blue™ Imaging System is Poised to…
K2-BioLabs offers “big company” resources that accommodate “small company” budgets Rapha Portfolio Company PONCE Therapeutics, Inc. is an investor and the first tenant of K2 Bio Houston, TX, June 14,…
Rapha Capital Management (RCM LLC) Joined by Mendham Investment Group (MIG FZ LLC) in Leading the Financing FIZE’s Novel iUO™ Device Conquers the Last Frontier in Patient Monitoring Rapha Capital’s…